PaceMate has announced the appointment of Benjamin A Steinberg as its chief medical officer (CMO).
Described by the company as a nationally recognised leader in cardiac electrophysiology, US National Institutes of Health (NIH)-funded researcher, and author of nearly 200 peer-reviewed publications, Steinberg is set to provide PaceMate with “a rare combination of clinical depth, research rigour and real-world expertise in applying AI [artificial intelligence] and data science to cardiac device management”.
As CMO, Steinberg will help shape PaceMate’s clinical direction, connecting its proprietary AI analytics engine to the clinical and scientific community, and ensuring the platform remains aligned with the needs of device clinics, health systems, and the patients they serve, as per a company press release.
“Dr Steinberg sits at a rare intersection: a practising electrophysiologist who also leads AI research at scale,” said PaceMate chief executive officer (CEO) J R Finkelmeier. “His work has shaped how the field approaches personalised care for patients with implantable devices, and now that expertise lives inside PaceMate. We have a CMO who has lived the clinical and operational challenges our platform is built to solve. Dr Steinberg is central to where PaceMate is headed.”
Steinberg serves as director of cardiac electrophysiology at Denver Health Medical Center (Denver, USA) and associate professor of medicine at the University of Colorado Anschutz Medical Campus (Aurora, USA), where he treats patients, and leads NIH-funded research applying machine learning and AI to arrhythmia diagnosis and implantable device management.
He is the principal investigator for multiple active NIH grants focused on personalised stroke risk stratification in atrial fibrillation (AF) and explainable AI for cardiac applications. Steinberg also holds leadership roles within the American College of Cardiology (ACC) and Heart Rhythm Society (HRS), and serves on multiple editorial boards.
“PaceMate has built something genuinely different: a platform that understands how device clinics actually work, across millions of patients, with the data infrastructure to generate insights at a scale previously not possible,” Steinberg commented. “As a clinician and researcher, I have spent my career asking how we use data to personalise care and improve outcomes. PaceMate is the place where that question gets answered in practice. I am thrilled to join this team and help drive the next generation of clinical intelligence in remote cardiac monitoring.”
